L a Multi-Dimensional Interactive Platform-Keynote Speeches+ Panel Discussions+ Project
Highlights:
l A multi-dimensional interactive platform-Keynote speeches+ panel discussions+ project showcase+ exhibition
l Authoritative trend analysis of Chinese biopharmaceutical industry-analysis on landscape of therapeutic biologics on a global scale
l A comprehensive showcase of internationally-leading biopharma technologies- immunotherapy+ precision medicine+ R&D and production of therapeutic biologics
l A detailed guide to decision-making of venture capital-great financing opportunities for biotech start-ups
l An array of projects promotion towards tech transfer, financing and M&A
l The greatest occasion to meet 200+ industry players
AGENDA
DAY ONE / DAY TWO9:00-12:10 / Meeting：Module 1 / Exhibition / 9:00-10:30 / Meeting：Module 5 / Exhibition
13:30-15:30 / Meeting：Module 2 / 10:50-12:00 / Project Showcase：
Module 6
15:50-18:30 / Parallel Meetings：Module 3-4
Chairperson：Mr. Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation
DAY 1：DEC.1, 2015Module 1: Industry Development and Updates on Regulatory Policies and Standards
Areas to be covered: Latest regulatory policies, assessment, standards and case studies
9:00
-9:10 / Opening Address from Chairman
Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation
9:10
-9:20 / Opening Address
Xu Ming, Vice President, CCCMHPIE
9:20
-9:50 / Building an Innovation-Driven Ecosystem for Bio-Pharma Industry in China
Joseph Cho, Managing Director, RDPAC
9:50
-10:20 / Current Development of Health Policy and Health Sector Innovation in China
John Cai, Director, Center for Healthcare Management and Policy of CEIBS
10:20
-10:50 / Regulating Therapeutic Biologics—A View Of Chinese New Pharmacopeia
Guo Zhongping , Director of biological standards division, Chinese Pharmacopoeia Commission
10:50
-11:10 / Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
11:10
-11:40 / Overview of the US Biologicals Market in the US and Ensuring Commercial Success.
Dr. Trey Putnam , VP and GM of Regulatory Science, Cardinal Health Specialty Solutions
11:40
-12:10 / Looking into 2016: Impact of the Financial Markets on Globalization
David Flores, President and CEO, BioCentury
12:10
-13:30 / Lunch
Module 2: Global Biopharmaceutical Market Dynamics
13:30
-14:00 / Regulation Of Biosimilars In the EU And Case Studies
-European Medicines Agency (TBC)
14:00
-14:30 / Key Consideration on Biologicals Review and Case Studies
-FDA
14:30
-15:00 / Overview of Biologics Standard Development at United States Pharmacopeia
-Bingbing Feng, Vice President and General Manager, USP-China
15:00
-15:30 / Research and Markets---Global Biologics Perspectives
-Zhou Feng, Product & Solution Specialist, Thomson Reuters
15:30
-15:50 / Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
15:50
-18:30 / Parallel Session / Module 3:
Immune therapy and Precision Medicine / Module 4:
R&D and Production of Therapeutic Biologics
Areas to be covered: Immunology, Precision, Innovation, Clinical
Moderator:
Xu Ming, Vice President, CCCMHPIE
Keynote 1:
Immunotherapy, Changing Landscape of Cancer Treatment
- Li Kang, Head of Biologics, BeiGene
Keynote 2: Genetic Technology and Precision Medicine
-Wang Hongqi,Vice President,BGI
Panel Discussion:
-Li Kang, Head of Biologics, BeiGene
- Wang Hongqi,Vice President,BGI
- Wang Yinxiang, President & CSO, Betta Pharmaceuticals
-Wu Yanzhuo, Vice President, Beijing SL Pharmaceutical
- Wang Jinliang, Deputy Director of Medical Oncology, Beijing 301 hospital / Areas to be covered:
R&D, Manufacturing process, Expression, Trend
Moderator:
Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation
Keynote 1:
Drug Targets in the Ubiquitin-Proteasome Pathway
-Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University
Keynote 2: Site-Specific ADC by Design-using an expanded genetic code
-Dr. Tian Feng, CSO, Ambrx
Panel Discussion:
-Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University
-Mr. Tian Feng, CSO, Ambrx
-Julius Li, CEO, AutekBio China
-Petr Janda, CEO, Accord Research
- Wang Haibin, Senior Vice President,
Hisun Pharmaceutical
DAY 2：DEC.2, 2015
9:00
-10:00 / Module 5: Biopharmaceuticals and Financing
Areas to be covered：Discovery, Technology, Capital, Integration
Moderator:
Che Yan, Strategy and Sales Excellence, Bayer China
Speakers to be invited:
-Sylvia He, Partner, CDH Investments
-Yin Jinqun, Vice President, KangHong Pharmaceutical Group
-Shao Qun, Deputy Director, Open Innovation University of Bradford
-Cao Xiaochun, Executive Vice President, Hangzhou Tigermed Consulting
- David Flores, President and CEO, BioCentury
10:00
-10:20 / Tea Break and Networking
Visit the exhibition area and to network with 200+ industrial peers
10:20
-12:30 / Module 6: Roadshow (Co-organizer: eChinaChem, Inc.)
Highlights of well selected Chinese and overseas projects for technology transfer, financing and M&A
Contacts:
Sharon Wu /Rosy Tu
China Chamber of Commerce for Import & Export of Medicines & Health Products
Tel: (8610) 58036296 13810176787/58036315 18611220076
E-mail：/